Welcome to the Pharmacy Web Page - Clinical resources for SIVUH staff

Improving access to guidelines to support prescribing and medication management has been a standing item for the hospital medication safety committee for some time. We have developed this page to improve access to the SIVUH IV administration guidelines. Click on the links below to open.

Guidelines are for SIVUH staff only. Every effort will be made for information to be up to date but this may not always be possible. Please contact pharmacy for advice if needed.

Pain

Multi-modal pain pathway_16Oct2023.pdf (Updated October 2023)

Anti-microbials

Vancomycin pathway V1 Review 08.2024

Gentamicin pathway V1 Review 08.2024

Antidotes

SIVUH Andexanet Alfa (Ondexxya) guideline 26.03.24. Version1.pdf (Uploaded 28/03/2024)

SIVUH Antidote List 26.03.24. Version 4.pdf (Uploaded 28/03/2024)

Electrolytes

SIVUH Hyperkalemia management 26.03.24. Version1.pdf (Uploaded 28/03/2024)

Appendix 6 High Alert Medications and IV Electrolyte Replacement Therapy Pathways

Agitation

SIVUH Rapid tranquilisation guideline 26.03.24. Version1.pdf (Uploaded 28/03/2024)

SIVUH Management of agitation in older people with delirium and/or dementia V1 May 2022

Preparation Information leaflets

Guideline for Tranexamic Acid Mouthwash for inpatients 26.03.24. Version1.pdf (Uploaded 28/03/2024)

Guideline for Tranexamic Acid Mouthwash on discharge (tablet) 26.03.24. Version1.pdf (Uploaded 28/03/2024)

Medication Safety Resources

Improving Proton pump inhibitors (PPIs) prescribing at SIVUH Poster 13.05.2024

HSE Proton pump inhibitors (PPIs) for the treatment of gastro-oesophageal reflux disease (GORD) V1 2019

Anticoagulation:

Guideline for venous thromboembolism thromboprophylaxis of patients undergoing lower limb arthroplasty (hip or knee joint replacement) at the South Infirmary Victoria University Hospital. Version 2. (Consider Kardex guidance for extremes of bodyweight)

These guidelines should be read and administered in conjunction with the specific administration notes applicable to each guideline.

*** End ***